M. P. M. van der Linden

Long‐term impact of delay in assessment of patients with early arthritis

M. P. M. van der Linden, Saskia le Cessie, Karim Raza et al. · Arthritis & Rheumatism · 2010 · 473 citations

Medicine, Clinical Sciences, Internal Medicine +14

Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands

Bas B. Oude Munnink, David F. Nieuwenhuijse, Mart L. Stein et al. · Nature Medicine · 2020 · 354 citations · Full text

Public Health, Bioinformatics, Public Health Practice +14

Predicting arthritis outcomes--what can be learned from the Leiden Early Arthritis Clinic?

D. P. C. de Rooy, M. P. M. van der Linden, R. Knevel et al. · Lara D. Veeken · 2010 · 294 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

Classification of rheumatoid arthritis: Comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteria

M. P. M. van der Linden, Rachel Knevel, T. Huizinga et al. · Arthritis & Rheumatism · 2010 · 261 citations

Medicine, Clinical Sciences, Internal Medicine +10

Value of anti–modified citrullinated vimentin and third‐generation anti–cyclic citrullinated peptide compared with second‐generation anti–cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis

M. P. M. van der Linden, Diane van der Woude, Andreea Ioan‐Facsinay et al. · Arthritis & Rheumatism · 2009 · 164 citations · Full text

Life Sciences, Immunology, Internal Medicine +17